Insulet | PODD - Le Bénéfice D'Exploitation

Prix De L'Action
219.84
Variation Quotidienne
-16.23 -6.88%
Mensuellement
-10.76%
Annuel
-13.94%
Q1 Prévisions
213.20




Le Bénéfice D'Exploitation Changement Date
Abbott USD 2.25B 73M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Cardinal Health USD 763M 9M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
J&J USD 5.59B 1.81B 2025-12
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Solventum Corp USD 105M 1.58B 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
West Pharmaceutical Services USD 162.5M 5.1M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12